Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
February-2015 Volume 11 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2015 Volume 11 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells

  • Authors:
    • Pengcheng Li
    • Hesong Zeng
    • Jin Qin
    • Yuanlin Zou
    • Dan  Peng
    • Houjuan Zuo
    • Zhengxiang Liu
  • View Affiliations / Copyright

    Affiliations: Departments of Cardiology and Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
  • Pages: 1258-1265
    |
    Published online on: October 27, 2014
       https://doi.org/10.3892/mmr.2014.2774
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Tetraspanin protein CD151 is overexpressed in a wide variety of cancer types, including lung cancer, and is closely associated with metastasis and poor prognosis of carcinoma. To investigate whether knockdown of CD151 expression can inhibit the malignant biological behavior of lung adenocarcinoma (LAC), RNA interference technology (RNAi) was used to silence CD151 expression in the A549 LAC cell line. Specific small interfering RNA (siRNA) for targeting human endogenous CD151 were delivered into A549 cells in order to examine the effects on cell proliferation, survival, migration, invasion and colony formation. The expression levels of CD151 were assayed by western blotting, proliferation was evaluated by MTT method and apoptosis was determined by flow cytometry. The invasive and metastatic ability of A549 cells was investigated by wound healing and Boyden chamber assays. Colony formation analysis was used to determine the A549 cell growth properties. Finally, the expression of phosphorylated FAK, PI3K‑AKT, MEK‑Erk1/2, MMPs, and VEGF was detected by western blotting. The results demonstrated that CD151‑siRNA significantly decreased the expression level of CD151 in A549 cells. Reduced CD151 expression in A549 cells lead to the inhibition of cellular proliferation, migration, invasion and colony formation and an enhancement of apoptosis. Furthermore, the expression of tumor development‑related proteins, including FAK, PI3K‑AKT, MEK‑ERK1/2MAPK as well as the expression of MMP9 and VEGF, were restrained. Taken together, the present study has shown that CD151 expression is essential for LAC progression. Thus, knockdown CD151 expression by targeted siRNA could inhibit the related downstream intercellular signaling pathways, and this may provide a novel gene therapy for patients with LAC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Bennett A and White J: Improving care and quality of life for patients with lung cancer. Nurs Stand. 28:50–58. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Oken MM, Hocking WG, Kvale PA, et al: Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 306:1865–1873. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Hanagiri T, Baba T, So T, et al: Time trends of surgical outcome in patients with non-small cell lung cancer. J Thorac Oncol. 5:825–829. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Sun X and Zheng Y: Retreatment with icotinib in a patient with metastatic lung adenocarcinoma. Tumori. 99:e124–e126. 2013.PubMed/NCBI

6 

Hashida H, Takabayashi A, Tokuhara T, et al: Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer. 89:158–167. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Kang BW, Lee D, Chung HY, et al: Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer. J Cancer Res Clin Oncol. 139:1835–1843. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Wang HX, Li Q, Sharma C, et al: Tetraspanin protein contributions to cancer. Biochem Soc Trance. 39:547–552. 2011. View Article : Google Scholar

9 

Yue S, Mu W and Zöller M: Tspan8 and CD151 promote metastasis by distinct mechanisms. Eur J Cancer. 49:2934–2948. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Copeland BT, Bowman MJ and Ashman LK: Genetic ablation of the tetraspanin CD151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model. Mol Cancer Res. 11:95–105. 2013. View Article : Google Scholar

11 

Chernousov MA, Stahl RC and Carey DJ: Tetraspanins are involved in Schwann cell-axon interaction. J Neurosci Res. 91:1419–1428. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Spring FA, Griffiths RE, Mankelow TJ, et al: Tetraspanins CD81 and CD82 facilitate α4β1-mediated adhesion of human erythroblasts to vascular cell adhesion molecule-1. PLoS One. 8:e626542013. View Article : Google Scholar

13 

Kwon MJ, Seo J, Kim YJ, et al: Prognostic significance of CD151 overexpression in non-small cell lung cancer. Lung Cancer. 81:109–116. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Ang J, Lijovic M, Ashman LK, et al: CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator? Cancer Epidemiol Biomarkers Prev. 13:1717–1721. 2004.PubMed/NCBI

15 

Lee D, Suh YL, Park TI, et al: Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas. J Surg Oncol. 107:646–652. 2013. View Article : Google Scholar

16 

Haeuw JF, Goetsch L, Bailly C, et al: Tetraspanin CD151 as a target for antibody-based cancer immunotherapy. Biochem Soc Trans. 39:553–558. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Minner S, De Silva C, Rink M, et al: Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer. Pathology. 44:448–452. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Ang J, Fang BL, Ashman LK, et al: The migration and invasion of human prostate cancer cell lines involves CD151 expression. Onco Rep. 24:1593–1597. 2010.

19 

Woegerbauer M, Thurnher D, Houben R, et al: Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression. Mod pathol. 23:751–762. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Yang W, Li P, Lin J, et al: CD151 promotes proliferation and migration of PC3 cells via the formation of CD151-integrin α3/α6 complex. J Huazhong Univ Sci Technolog Med Sci. 32:383–388. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Gottumukkala SN, Dwarakanath CD and Sudarsan S: Ribonucleic acid interference induced gene knockdown. J Indian Soc Periodontol. 17:417–422. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Wilson RC and Doudna JA: Molecular mechanisms of RNA interference. Annu Rev Biophys. 42:217–239. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Fujishima S, Shiomi T, Yamashita S, et al: Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis. Arch Pathol Lab Med. 134:1136–1142. 2010.PubMed/NCBI

24 

Hong IK, Jin YJ, Byun HJ, et al: Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J Biol Chem. 281:24279–24292. 2006. View Article : Google Scholar : PubMed/NCBI

25 

Ogorevc E, Kralj-Iglic V and Veranic P: The role of extracellular vesicles in phenotypic cancer transformation. Radiol Oncol. 47:197–205. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Olbryt M: Role of tumor microenvironment in the formation and progression of skin melanoma. Postepy Hig Med Dosw (Online). 67:413–432. 2013.(In Polish). View Article : Google Scholar

27 

Wang HX, Li Q, Sharma C, et al: Tetraspanin protein contributions to cancer. Biochem Soc Trans. 39:547–552. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Romanska HM and Berditchevski F: Tetraspanins in human epithelial malignancies. J Pathol. 223:4–14. 2011. View Article : Google Scholar

29 

Takeda Y, Kazarov AR, Butterfield CE, et al: Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood. 109:1524–1532. 2007. View Article : Google Scholar

30 

Yañez-Mó M, Barreiro O, Gonzalo P, et al: MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells. Blood. 112:3217–3226. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Devbhandari RP, Shi GM, Ke AW, et al: Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma. PLoS One. 6:e249012011. View Article : Google Scholar

32 

Colin S, Guilmain W, Creoff E, et al: A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth. Br J Cancer. 105:1002–1011. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Charrin S, Manié S, Billard M, et al: Multiple levels of interactions within the tetraspanin web. Biochem Biophys Res Commun. 304:107–112. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li P, Zeng H, Qin J, Zou Y, Peng D, Zuo H and Liu Z: Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells. Mol Med Rep 11: 1258-1265, 2015.
APA
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., & Liu, Z. (2015). Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells. Molecular Medicine Reports, 11, 1258-1265. https://doi.org/10.3892/mmr.2014.2774
MLA
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., Liu, Z."Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells". Molecular Medicine Reports 11.2 (2015): 1258-1265.
Chicago
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., Liu, Z."Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells". Molecular Medicine Reports 11, no. 2 (2015): 1258-1265. https://doi.org/10.3892/mmr.2014.2774
Copy and paste a formatted citation
x
Spandidos Publications style
Li P, Zeng H, Qin J, Zou Y, Peng D, Zuo H and Liu Z: Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells. Mol Med Rep 11: 1258-1265, 2015.
APA
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., & Liu, Z. (2015). Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells. Molecular Medicine Reports, 11, 1258-1265. https://doi.org/10.3892/mmr.2014.2774
MLA
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., Liu, Z."Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells". Molecular Medicine Reports 11.2 (2015): 1258-1265.
Chicago
Li, P., Zeng, H., Qin, J., Zou, Y., Peng, D., Zuo, H., Liu, Z."Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells". Molecular Medicine Reports 11, no. 2 (2015): 1258-1265. https://doi.org/10.3892/mmr.2014.2774
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team